OatMeal and Insulin Resistance: OMA-IR
NCT00401453 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2010-02-17
Summary
Insulin resistance is a central feature of Diabetes mellitus type 2 (Stumvoll et al. 2005). Hypo- and hyperglycemic states are associated with adverse inpatient outcomes (ADA et al. 2006 Diab Care) and with the development of microvascular complications (UKPDS 34 Lancet 1998).
A long known therapy for the acute treatment of patients with deteriorated glucose metabolism and insulin resistance are carbohydrate days. The principle of the therapy was firstly introduced in 1903 by Carl von Noorden (Noorden et al. 1903). The diabetic patients were treated for several days with a carbohydrate rich diet with fat restriction. Surprisingly, this resulted in an amelioration of glucosuria. Today it's still a valuable tool for patients with uncontrollable diabetes mellitus and severe insulin resistance (Willms B. 1989). But up to now there has been no systemic evaluation of carbohydrate days in patients with deteriorated Diabetes mellitus and insulin resistance.
The investigators conducted a pilot study with 14 patients to evaluate the efficacy of two days of oatmeal on insulin resistance and glucose metabolism in an acute clinical setting and after a four week outpatient period. Inclusion criteria were type 2 diabetes with deteriorated glucose metabolism, insulin resistance defined as an insulin dosage of more than 1 U per day and kg bodyweight. Within this pilot trial the investigators found a marked decrease of insulin requirements (\~40%) and mean daily blood glucose to a mean blood glucose of 114.7±36.7 mg/dl in the acute setting as well as after the four week outpatient period (Lammert et al. 2006).
The most important shortcomings of this study were the hypocaloric interventions in both groups (diabetes-adapted diet: 1500kcal/d vs. oatmeal 1200kcal/d) making it difficult to attribute the observed effects to oatmeal alone as well as the uncontrolled nature. These design flaws have been addressed within this new clinical trial. The investigators plan an open label, cross-over study with isocaloric interventions (oatmeal and diabetes-adapted diet: \~ 1200kcal/d). The intervention comprises two days of oatmeal (third and fourth day) within a 5 day hospital stay. The control is only treated with 5 days of diabetes adapted diet. Thereafter, the patients are followed every four weeks for an overall of 16 weeks.
Conditions
- Diabetes Mellitus Type 2
- Insulin Resistance
Interventions
- BEHAVIORAL
-
Diet: carbohydrate days. (Name: oatmeal.)
Dietary intervention with two days of oatmeal compared to normal diabetes adapted diet in insulin resistant subjects.
Sponsors & Collaborators
-
Universitätsmedizin Mannheim
lead OTHER
Principal Investigators
-
Hans-Peter Hammes, PhD · fifth medical clinic, university hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
-
Alexander Lammert, MD · fifth medical clinic, University hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2010-02-28
- Completion
- 2010-02-28
Countries
- Germany
Study Locations
More Related Trials
-
Glycemic Response in Adults With Type 2 Diabetes
NCT05166200 ·Status: COMPLETED ·Phase: NA
-
Metabolic Activation With Almased for Type 2 Diabetes Patients
NCT01680926 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus Patients
NCT05654805 ·Status: UNKNOWN ·Phase: NA
-
The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes
NCT04509245 ·Status: COMPLETED ·Phase: NA
-
Effect of Consuming Oat Bran Mixed in Water Before a Meal on Glycemic Responses in Healthy Humans - a Pilot Study
NCT02801916 ·Status: COMPLETED ·Phase: NA
-
Almond Butter and Fasting Glucose
NCT03826472 ·Status: COMPLETED ·Phase: PHASE2
-
Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response
NCT05291806 ·Status: COMPLETED ·Phase: NA
-
Time Restricted Eating As Treatment (TREAT) for Diabetes Mellitus: A Pre-Post 12 Week Study on the Effectiveness of Intermittent Fasting in Asians With Type 2 Diabetes Mellitus
NCT03940482 ·Status: UNKNOWN ·Phase: NA
-
Glycemic Index in Subjects With Diabetes Mellitus Insulin Requesting
NCT02881164 ·Status: COMPLETED ·Phase: NA
-
Impact of Branched-chain Amino Acids in the Development of Insulin Resistance
NCT03261362 ·Status: COMPLETED ·Phase: NA
-
Nutritional Prevention of Diabetes Mellitus Type 2
NCT03231839 ·Status: COMPLETED ·Phase: NA
-
The Effect of Meal Replacement on the Time to Reach the Blood Glucose Target in Patients With Type 2 Diabetes Mellitus
NCT05365152 ·Status: UNKNOWN ·Phase: NA
-
Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes
NCT00753181 ·Status: COMPLETED ·Phase: PHASE3
-
Wholegrain Cereal Diet and Insulin Sensitivity
NCT00945854 ·Status: COMPLETED ·Phase: NA
-
Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes
NCT03758742 ·Status: COMPLETED ·Phase: NA
-
Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid
NCT03430310 ·Status: COMPLETED ·Phase: NA
-
Metabolic Response of Slow Released Carbohydrates in Diabetes Mellitus
NCT01070238 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes Patients
NCT04279444 ·Status: COMPLETED ·Phase: NA
-
Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes
NCT03829800 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride
NCT03917940 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)
NCT07286747 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Carrageenan's Effect on Insulin Resistance in Humans
NCT02629705 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study Evaluating Oat Polyphenols on Post-prandial Glucose Response
NCT04260425 ·Status: COMPLETED ·Phase: NA
-
Exploring Buckwheat's Glucose Lowering Potential
NCT00841503 ·Status: COMPLETED
-
Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses
NCT03257059 ·Status: COMPLETED ·Phase: NA